补体系统激活参与阿尔茨海默病的研究进展  

Research progress on the activation of complement system is involved in the pathogenesis of Alzheimer's disease

作　　者：慕静然 骆延 梁璇 徐陶 曾俊伟 刘晓红 MU Jingran;LUO Yan;LIANG Xuan;XU Tao;ZENG Junwei;LIU Xiaohong(Department of Physiology,Zunyi Medical University,Zunyi 563000,China)

机构地区：[1]遵义医科大学生理学教研室,563000

出　　处：《天津医药》2024年第6期663-668,共6页Tianjin Medical Journal

基　　金：国家自然科学基金资助项目(81960161,31860291);贵州省教育厅创新群体重大研究项目(黔教合KY字[2018]025)。

摘　　要：阿尔茨海默病(AD)是一种常见的神经系统退行性疾病。补体系统激活在AD病变进程中发挥了重要作用,活化的补体可与膜受体结合,调节下游信号发挥作用。抑制补体激活为AD治疗提供了新思路。就有关补体系统激活参与AD病变的机制以及相应的药物研发进展进行综述,以期为AD的诊断、治疗及药物研发提供新观点。Alzheimer's disease(AD)is a common neurodegenerative disease,which is mainly caused by brain lesions.The activation of complement system plays an important role in the process of AD lesions.The activated complement can bind to cell membrane receptors and regulate downstream signals.Therefore,inhibiting complement activation provides a new idea for AD treatment.This article reviews the progress in the mechanism and drug development of complement activation in AD,which may provide a new perspective for the diagnosis,treatment and drug development of AD.

关 键 词：阿尔茨海默病 补体系统蛋白质类 淀粉样β肽类 突触 TAU蛋白质类 胶质细胞 神经炎症 

分 类 号：R745.7[医药卫生—神经病学与精神病学]